Clinical Trial Update: Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years [Phase 1]

View source ↗

Summary

Phase 1 dose-finding study evaluating four dosage levels of an H7N9 influenza vaccine in adults aged 18-65; study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• H7n9 Influenza

Drugs mentioned

• Novartis H7N9 influenza vaccine (unspecified formulation in dataset)

Snippet

Sponsor: Novartis Vaccines | Conditions: H7N9 Influenza | Phase 1 | Status: COMPLETED | Results posted: 2015-05-21